Human Papillomavirus-Related Malignant Neoplasm

Human Papillomavirus-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

168 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 37
Ph III recruiting: 2
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03799445	Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma	terminated	Phase 2	37	M.D. Anderson Cancer CenterOTHER	1	Apr 30, 2026	clinicaltrials
NCT03601507	Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer	terminated	Phase 2	9	University of ArizonaOTHER	1	Apr 17, 2024	clinicaltrials